This inventor holds 2 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignee: The General Hospital Corporation. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Innovations by Anna Moore
Introduction
Anna Moore is a notable inventor based in Stoneham, MA (US). She has made significant contributions to the field of biomedical imaging, particularly in the study of amyloid beta and its implications in various diseases. With a total of 2 patents, her work has garnered attention for its potential impact on medical diagnostics and treatment.
Latest Patents
Among her latest patents is the invention titled "Half-curcuminoids as amyloid-β PET imaging agents." This patent describes curcumin analogues that can interact with amyloid beta (Aβ) and reduce the copper-induced crosslinking of Aβ. The patent also outlines methods for using these compounds as imaging agents for amyloid beta and for treating diseases associated with it. Additionally, it includes methods for preparing both unlabeled and radiolabeled compounds that are useful in interacting with amyloid beta, along with pharmaceutical compositions.
Career Highlights
Throughout her career, Anna has worked with reputable organizations, including The General Hospital Corporation and Uti Limited Partnership. Her experience in these institutions has allowed her to collaborate with leading experts in her field and contribute to groundbreaking research.
Collaborations
Some of her notable coworkers include Chongzhao Ran and Jian Yang. Their collaborative efforts have further advanced the research surrounding amyloid beta and its implications in health.
Conclusion
Anna Moore's innovative work in the field of biomedical imaging highlights her dedication to advancing medical science. Her patents and collaborations reflect her commitment to improving diagnostic methods and treatment options for diseases associated with amyloid beta.